Watch Ticker

Organogenesis Holdings Inc. Class A Common Stock

Go to Organogenesis Holdings Inc. Class A Common Stock Website

$4.53

0.00 (0.00%)

Live

Previous Close

$4.53

Day Range

$0 - $0

Previous Day Range

$4.495 - $4.67

Market Cap

$583.5 million USD

Day Vol.

Previous Day Vol.

462405

Currency

USD

Primary Exchange

Nasdaq

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerat...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - Global Amniotic Membrane Market Poised for Extraordinary Growth at a CAGR of ~7% by 2032 | DelveInsight

The global amniotic membrane market is expected to grow at a 7% CAGR by 2032, driven by increasing demand for advanced wound healing treatments and ophthalmological applications, with North America leading market expansion.

Related tickers: ORGO, AXGN.

Read Full Article

The Motley Fool - Organogenesis (ORGO) Q4 2024 Earnings Call Transcript

Organogenesis Holdings Inc. reported strong Q4 2024 revenue growth of 27%, driven by better-than-expected customer demand. However, the company expects a challenging operating environment in the first half of 2025 due to delays in the implementation of new Medicare coverage policies for skin substitute products. The company provided financial guidance for 2025 and updated on the progress of its ReNu clinical program.

Related tickers: ORGO.

Read Full Article

Trending Tickers

Please sign in to view